Published in Am J Ophthalmol on August 01, 2004
Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone. Clin Ophthalmol (2008) 2.20
Vehicle of triamcinolone acetonide is associated with retinal toxicity and transient increase of lens density. Graefes Arch Clin Exp Ophthalmol (2006) 1.60
Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography study. Br J Ophthalmol (2006) 1.05
One-year results of a multicenter controlled clinical trial of triamcinolone in pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol (2008) 0.89
Impact of injection techniques on intraocular pressure (IOP) increase after intravitreal ranibizumab application. Graefes Arch Clin Exp Ophthalmol (2010) 0.88
Comparison of 4 mg versus 20 mg intravitreal triamcinolone acetonide injections. Br J Ophthalmol (2008) 0.84
Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes. Jpn J Ophthalmol (2009) 0.82
Postoperative outcomes after fluocinolone acetonide implant surgery in patients with birdshot chorioretinitis and other types of posterior and panuveitis. Retina (2013) 0.82
Short-term intraocular pressure changes after intravitreal injection of bevacizumab in diabetic retinopathy patients. Clin Ophthalmol (2014) 0.79
Intraocular pressure following intravitreal injection of triamcinolone acetonide. Open Ophthalmol J (2008) 0.77
Intraocular pressure rise after intravitreal triamcinolone. Am J Ophthalmol (2005) 0.77
Selective laser trabeculoplasty for elevated intraocular pressure following subtenon injection of triamcinolone acetonide. Clin Ophthalmol (2010) 0.77
Outcome of primary trabeculotomy ab interno (Trabectome) surgery in patients with steroid-induced glaucoma. Medicine (Baltimore) (2016) 0.77
Impact on intraocular pressure after 20-mg decanted triamcinolone acetonide (kenalog) injection when using prophylactic antiglaucoma therapy. Retina (2015) 0.76
Management of intractable glaucoma following intravitreal triamcinolone acetonide. Am J Ophthalmol (2005) 0.76
Long-term effect of anti-vascular endothelial growth factor injections on intraocular pressure. Indian J Ophthalmol (2016) 0.75
Effects of triamcinolone acetonide on human trabecular meshwork cells in vitro. Indian J Ophthalmol (2014) 0.75
Glucocorticoid therapy and ocular hypertension. Eur J Pharmacol (2016) 0.75
Steroid-induced Glaucoma: An Avoidable Irreversible Blindness. J Curr Glaucoma Pract (2017) 0.75
Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology (2003) 8.98
Three-year follow-up of the tube versus trabeculectomy study. Am J Ophthalmol (2009) 4.21
Cerebrospinal fluid pressure is decreased in primary open-angle glaucoma. Ophthalmology (2008) 4.09
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol (2012) 3.93
Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol (2006) 3.66
Surgical complications in the Tube Versus Trabeculectomy Study during the first year of follow-up. Am J Ophthalmol (2006) 2.94
The economic burden of major adult visual disorders in the United States. Arch Ophthalmol (2006) 2.92
A critical appraisal and comparison of the quality and recommendations of glaucoma clinical practice guidelines. Ophthalmology (2011) 2.82
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol (2012) 2.82
Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up. Am J Ophthalmol (2006) 2.73
The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States. Ophthalmology (2009) 2.57
Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration. Am J Ophthalmol (2011) 2.07
High failure rate associated with 180 degrees selective laser trabeculoplasty. J Glaucoma (2005) 2.03
Glaucoma Progression Analysis software compared with expert consensus opinion in the detection of visual field progression in glaucoma. Ophthalmology (2011) 2.01
Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma. PLoS Genet (2012) 2.00
Longitudinal rates of postoperative adverse outcomes after glaucoma surgery among medicare beneficiaries 1994 to 2005. Ophthalmology (2008) 1.88
Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma. Mol Vis (2008) 1.87
Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma. Am J Ophthalmol (2010) 1.66
Hypothyroidism and the development of open-angle glaucoma in a male population. Ophthalmology (2004) 1.63
Health literacy and adherence to glaucoma therapy. Am J Ophthalmol (2006) 1.57
Eye care in the United States: do we deliver to high-risk people who can benefit most from it? Arch Ophthalmol (2007) 1.53
Distribution of WDR36 DNA sequence variants in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci (2006) 1.51
Lack of association between LOXL1 variants and primary open-angle glaucoma in three different populations. Invest Ophthalmol Vis Sci (2008) 1.51
Genome-wide association analyses identify multiple loci associated with central corneal thickness and keratoconus. Nat Genet (2013) 1.49
Clinical comparison of the Proview eye pressure monitor with the Goldmann applanation tonometer and the Tonopen. Arch Ophthalmol (2004) 1.48
One-year outcomes after retinal detachment surgery among medicare beneficiaries. Am J Ophthalmol (2010) 1.48
Molecular genetics in glaucoma. Exp Eye Res (2011) 1.47
Evaluation of the relationship between ablation diameter, pupil size, and visual function with vision-specific quality-of-life measures after laser in situ keratomileusis. Arch Ophthalmol (2007) 1.47
An assessment of the health and economic burdens of glaucoma. Am J Ophthalmol (2011) 1.46
Ten-year incidence of age-related macular degeneration according to diabetic retinopathy classification among medicare beneficiaries. Retina (2013) 1.46
Major LOXL1 risk allele is reversed in exfoliation glaucoma in a black South African population. Mol Vis (2010) 1.45
Resident physician mentoring program in ophthalmology: the Tennessee experience. Arch Ophthalmol (2006) 1.44
A comparison of the Ex-PRESS™ mini glaucoma shunt with standard trabeculectomy in the surgical treatment of glaucoma. Ophthalmic Surg Lasers Imaging (2011) 1.41
Intracranial pressure in primary open angle glaucoma, normal tension glaucoma, and ocular hypertension: a case-control study. Invest Ophthalmol Vis Sci (2008) 1.40
Estimates of incidence rates with longitudinal claims data. Arch Ophthalmol (2003) 1.37
Genome-wide expression profile of human trabecular meshwork cultured cells, nonglaucomatous and primary open angle glaucoma tissue. Mol Vis (2006) 1.35
Identification of patients with diabetic macular edema from claims data: a validation study. Arch Ophthalmol (2008) 1.33
Cellular senescence in the glaucomatous outflow pathway. Exp Gerontol (2005) 1.32
Replication of TCF4 through association and linkage studies in late-onset Fuchs endothelial corneal dystrophy. PLoS One (2011) 1.30
Vision-related quality of life in people with central retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol (2003) 1.29
Patterns of care for open-angle glaucoma in managed care. Arch Ophthalmol (2003) 1.28
Survey of glaucoma in an eye clinic in Ghana, West Africa. J Glaucoma (2002) 1.26
Resource use and costs associated with diabetic macular edema in elderly persons. Arch Ophthalmol (2008) 1.25
Development of a patient satisfaction survey for outpatient care: a brief report. J Med Pract Manage (2004) 1.25
High-risk populations for vision loss and eye care underutilization: a review of the literature and ideas on moving forward. Surv Ophthalmol (2013) 1.24
Monitoring visual status: why patients do or do not comply with practice guidelines. Health Serv Res (2004) 1.20
Longitudinal rates of cataract surgery. Arch Ophthalmol (2006) 1.18
Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degeneration. Arch Ophthalmol (2011) 1.16
Lack of association of mutations in optineurin with disease in patients with adult-onset primary open-angle glaucoma. Arch Ophthalmol (2003) 1.15
Statins and other cholesterol-lowering medications and the presence of glaucoma. Arch Ophthalmol (2004) 1.15
Uveitis in the elderly: epidemiological data from the National Long-term Care Survey Medicare Cohort. Ophthalmology (2006) 1.12
Characterization and prevalence of PITX2 microdeletions and mutations in Axenfeld-Rieger malformations. Invest Ophthalmol Vis Sci (2004) 1.12
Characteristics of low-vision rehabilitation services in the United States. Arch Ophthalmol (2009) 1.12
Body mass index has a linear relationship with cerebrospinal fluid pressure. Invest Ophthalmol Vis Sci (2012) 1.11
Vision-related quality of life in persons with unilateral branch retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire. Br J Ophthalmol (2009) 1.10
Patient expectations for medical and surgical care: a review of the literature and applications to ophthalmology. Surv Ophthalmol (2004) 1.10
Longitudinal incidence of adverse outcomes of age-related macular degeneration. Arch Ophthalmol (2009) 1.10
Investigation of known genetic risk factors for primary open angle glaucoma in two populations of African ancestry. Invest Ophthalmol Vis Sci (2013) 1.10
The methodology of visual field testing with frequency doubling technology in the National Health and Nutrition Examination Survey, 2005-2006. Ophthalmic Epidemiol (2010) 1.09
Analysis of LOXL1 polymorphisms in a Saudi Arabian population with pseudoexfoliation glaucoma. Mol Vis (2010) 1.09
Intracranial pressure and glaucoma. Curr Opin Ophthalmol (2010) 1.08
No evidence of association of heterozygous NTF4 mutations in patients with primary open-angle glaucoma. Am J Hum Genet (2010) 1.08
The clinical utility of dynamic contour tonometry and ocular pulse amplitude. J Glaucoma (2007) 1.08
Screening of CYP1B1 and LTBP2 genes in Saudi families with primary congenital glaucoma: genotype-phenotype correlation. Mol Vis (2011) 1.07
Extracellular release of ATP mediated by cyclic mechanical stress leads to mobilization of AA in trabecular meshwork cells. Invest Ophthalmol Vis Sci (2009) 1.07
Genome-wide analysis of central corneal thickness in primary open-angle glaucoma cases in the NEIGHBOR and GLAUGEN consortia. Invest Ophthalmol Vis Sci (2012) 1.06
Confirmation of TBK1 duplication in normal tension glaucoma. Exp Eye Res (2012) 1.06
Aqueous humor in primary open-angle glaucoma contains an increased level of CD44S. Invest Ophthalmol Vis Sci (2002) 1.05
A modeled economic analysis of a digital tele-ophthalmology system as used by three federal health care agencies for detecting proliferative diabetic retinopathy. Telemed J E Health (2005) 1.05
Use of a standardized patient satisfaction questionnaire to assess the quality of care provided by ophthalmology residents. Ophthalmology (2007) 1.05
Understanding the importance of IOP variables in glaucoma: a systematic review. Surv Ophthalmol (2009) 1.05
Specific targeting of gene expression to a subset of human trabecular meshwork cells using the chitinase 3-like 1 promoter. Invest Ophthalmol Vis Sci (2005) 1.03
Patient expectations regarding eye care: focus group results. Arch Ophthalmol (2003) 1.02
Effects of receipt of guideline-recommended care on onset of diabetic retinopathy and its progression. Ophthalmology (2009) 1.02
Medicare costs for neovascular age-related macular degeneration, 1994-2007. Am J Ophthalmol (2011) 1.02
Novel software strategy for glaucoma diagnosis: asymmetry analysis of retinal thickness. Arch Ophthalmol (2011) 1.00
Effects of donor age on proteasome activity and senescence in trabecular meshwork cells. Biochem Biophys Res Commun (2004) 1.00
Ankyrin-B syndrome: enhanced cardiac function balanced by risk of cardiac death and premature senescence. PLoS One (2007) 1.00
Adherence to guidelines and its effects on hospitalizations with complications of type 2 diabetes. Rev Diabet Stud (2004) 1.00
Interobserver agreement and intraobserver reproducibility of the subjective determination of glaucomatous visual field progression. Ophthalmology (2010) 1.00
Mechanisms of action and efficacy of argon laser trabeculoplasty and selective laser trabeculoplasty. Curr Opin Ophthalmol (2007) 0.99
Socioeconomic disparity in use of eye care services among US adults with age-related eye diseases: National Health Interview Survey, 2002 and 2008. JAMA Ophthalmol (2013) 0.99
Effects of changes in self-reported vision on cognitive, affective, and functional status and living arrangements among the elderly. Am J Ophthalmol (2005) 0.99
Outcomes of surgical bleb revision for complications of trabeculectomy. Ophthalmology (2009) 0.99
No association between OPA1 polymorphisms and primary open-angle glaucoma in three different populations. Mol Vis (2007) 0.98
Genome-wide association study and meta-analysis of intraocular pressure. Hum Genet (2013) 0.98
Resveratrol prevents the expression of glaucoma markers induced by chronic oxidative stress in trabecular meshwork cells. Food Chem Toxicol (2008) 0.98
Patient satisfaction instruments used at academic medical centers: results of a survey. Am J Med Qual (2004) 0.97